Neuroprotective effect of thymoquinone, the Nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model

Iranian Journal of Pharmaceutical Research

Volumn 13, Issue 1, 2014, Pages 227-234

  Sedaghat, Reza ^a   Roghani, Mehrdad ^a   Khalili, Mohsen ^a  

^a SHAHED UNIVERSITY   (Iran)

Author keywords

6 hydroxydopamine; Oxidative stress; Parkinson's disease; Thymoquinone

Indexed keywords

MALONALDEHYDE; NITRITE; OXIDOPAMINE; SUPEROXIDE DISMUTASE; THYMOQUINONE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOMORPHINE TEST; ARTICLE; BEHAVIOR; BLACK CUMIN; CELL COUNT; CONTROLLED STUDY; HISTOLOGY; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PROTEIN DETERMINATION; RAT; SUBSTANTIA NIGRA PARS COMPACTA;

EID: 84903600611     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Reyhani-rad S, Nayebi A, Mahmoudi J, Samini M, and Babapour V. Role of 5-Hydroxytryptamine 1A Receptors in 6-Hydroxydopmaine-induced Catalepsy-like Immobilization in Rats: a Therapeutic Approach for Treating Catalepsy of Parkinson's Disease. Iran. J. Pharm. Res. (2012) 11: 1175-1181.
2. Garcia Ruiz PJ,Catalan MJ and Fernandez Carril JM. Initial motor symptoms of Parkinson disease. Neurologist (2011) 17: 18-20.
3. Roghani M, Niknam A, Jalali-Nadoushan MR, Kiasalari Z, Khalili M and Baluchnejadmojarad T. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism. Brain Res. Bull. (2010) 82: 279-83.
4. Schober A. Classic toxin-induced animal models of Parkinson>s disease: 6-OHDA and MPTP. Cell Tissue Res. (2004) 318: 215-224.
5. Mu X, He G, Cheng Y, Li X, Xu B and Du G. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in-vivo and in-vitro. Pharmacol. Biochem. Behav. (2009) 92: 642-648.
6. Henchcliffe C and Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol. (2008) 4: 600-609.
7. Sepand MR, Soodi Maliheh, Hajimehdipoor H and Sahraei E. Comparison of neuroprotective effects of Melissa officinalis total extract and its acidic and non-acidic fractions against Aβ-induced toxicity. Iran. J. Pharm. Res. (2013) 12: 415-23.
8. Hassan S, Ahmed W, Galeb FM, El-Taweel M and A Abu-Bedair. In Vitro Challenge using Thymoquinone on Hepatocellular Carcinoma (HepG2) Cell Line. Iran. J. Pharm. Res. (2008) 7: 283-290.
9. Khan A, Vaibhav K, Javed H, Moshahid Khan M, Tabassum R, Ahmed ME, Srivastava P, Khuwaja G, Islam F, Saeed Siddiqui M and Shafi MM. Attenuation of A beta-induced neurotoxicity by thymoquinone via inhibition of mitochondrial dysfunction and oxidative stress. Mol. Cell Biochem. (2012) 369: 55-65.
10. Ullah I, Ullah N, Naseer MI, Lee HY and Kim MO. Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons. BMC. Neurosci. (2012) 13: 11.
11. Mousavi SH, Tayarani-Najaran Z, Asghari M and Sadeghnia HR. Protective effect of Nigella sativa extract and thymoquinone on serum/glucose deprivation-induced PC12 cells death. Cell Mol. Neurobiol. (2010) 30: 591-598.
12. Kanter M. Protective effects of thymoquinone on the neuronal injury in frontal cortex after chronic toluene exposure. J. Mol. Histol. (2011) 42: 39-46.
13. Radad K, Moldzio R, Taha M and Rausch WD. Thymoquinone protects dopaminergic neurons against MPP+ and rotenone. Phytother. Res. (2009) 23: 696-700.
14. nd ed., Academic Press, San Diego (1986).
15. Baluchnejadmojarad T and Roghani M. Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress. Behav. Brain Res. (2011) 224: 305-310.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. (1976) 72: 248-54.
17. Baluchnejadmojarad T, Roghani M and Mafakheri M. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neurosci. Lett. (2010) 480: 206-210.
18. Schapira AH and Jenner P. Etiology and pathogenesis of Parkinson>s disease. Mov. Disord. (2011) 26: 1049-1055.
19. Schwarting RK and Huston JP. Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions. Neurotoxicology (1997) 18: 689-708.
20. Shapiro RM, Glick SD and Camarota NA. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation. Brain Res. (1987) 426: 323-331.
21. Guo S, Yan J, Yang T, Yang X, Bezard E and Zhao B. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson>s disease through inhibition of ROS-NO pathway. Biol. Psychiatry (2007) 62: 1353-1362.
22. Foley P and Riederer P. Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson>s disease. J. Neurol. (2000) 247: 82-94.
23. Chen S and Le W. Neuroprotective therapy in Parkinson disease. Am. J. Ther. (2006) 13: 445-57.
24. Oguz S, Kanter M, Erboga M and Erenoglu C. Protective effects of thymoquinone against cholestatic oxidative stress and hepatic damage after biliary obstruction in rats. J. Mol. Histol. (2012) 43: 151-9.
25. Zhou F, Wu JY, Sun XL, Yao HH, Ding JH and Hu G. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation. Neuropsychopharmacology (2007) 32: 2570-2580.
26. Sriram K and OCallaghan JP. Divergent roles for tumor necrosis factor-alpha in the brain. J. Neuroimmune Pharmacol. (2007) 2: 140-153.
27. El Gazzar M, El Mezayen R, Marecki JC, Nicolls MR, Canastar A and Dreskin SC. Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int. Immunopharmacol. (2006) 6: 1135-1142.
28. Vaillancourt F, Silva P, Shi Q, Fahmi H, Fernandes JC and Benderdour M. Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. J. Cell Biochem. (2011) 112: 107-117.
29. Hwang CK and Chun HS. Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons. Biosci. Biotechnol. Biochem. (2012) 76: 536-543.
30. Khan MM, Ahmad A, Ishrat T, Khan MB, Hoda MN, Khuwaja G, Raza SS, Khan A, Javed H, Vaibhav K and Islam F. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson>s disease. Brain Res. (2010) 1328: 139-151.
31. Chandra S, Mondal D and Agrawal KC. HIV-1 protease inhibitor induced oxidative stress suppresses glucose stimulated insulin release: protection with thymoquinone. Exp. Biol. Med. (Maywood) (2009) 234: 442-453.